{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:10:56Z","timestamp":1794672656882,"version":"4.9.1"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>\n                    Myeloid sarcoma (MS) is an extramedullary tumor of immature myeloid cells. We analyzed 131 patients with MS, including: (1) de novo MS; (2) MS with concomitant acute myeloid leukemia (AML); (3) MS following myelodysplastic syndrome, myeloproliferative neoplasm, or chronic myelogenous leukemia; and (4) MS as a recurrence of AML. The most common development site was the lymph node. Testicular lesions were statistically more frequent in MS as a recurrence of AML than in other types of MS (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0183). MS tended to lack myeloid markers (myeloperoxidase was present in 63.2%, CD68 in 51.3%, CD13 in 48.7%, and CD33 in 48.7% of patients) and express T-cell markers such as CD3 (20.7%) and CD5 (34.2%). All T-cell marker\u2013positive MS cases were negative for the \u03b1\u03b2 and \u03b3\u03b4 T-cell receptors on immunohistochemistry. Underlying myelodysplastic syndrome or myeloproliferative neoplasm was a poor prognostic factor (vs. de novo MS:\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0383; vs. MS with concomitant AML:\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0143). However, there was no statistical difference in prognosis between de novo MS and MS with concomitant AML (\n                    <jats:italic toggle=\"yes\">P=<\/jats:italic>\n                    0.288). There were no significant differences in prognosis between the prognoses of T-cell marker\u2013positive and T-cell marker\u2013negative MS cases. In addition, CXCR4 expression was a poor prognostic factor in MS (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0229). This study involves the largest MS cohort to date and expands the clinical and pathologic knowledge of the disease.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000000727","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T05:11:17Z","timestamp":1473916277000},"page":"1473-1483","source":"Crossref","is-referenced-by-count":103,"title":["Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients"],"prefix":"10.1097","volume":"40","author":[{"given":"Keisuke","family":"Kawamoto","sequence":"first","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata"},{"name":"Department of Pathology, School of Medicine, Kurume University, Kurume, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Kurume University, Kurume, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Kurume University, Kurume, Japan"},{"name":"Dana-Farber Cancer Institute, Medical Oncology, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Takizawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Sone","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Kurume University, Kurume, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","first-page":"83","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview","volume":"102","author":"Sabattini","year":"2010","journal-title":"Pathologica"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/1097-0142(19810915)48:6<1426::AID-CNCR2820480626>3.0.CO;2-G","article-title":"Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases","volume":"48","author":"Neiman","year":"1981","journal-title":"Cancer"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2559.1999.00651.x","article-title":"Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases","volume":"34","author":"Menasce","year":"1999","journal-title":"Histopathology"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/sj.leu.2402958","article-title":"Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy","volume":"17","author":"Tsimberidou","year":"2003","journal-title":"Leukemia"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1080\/10428190600967196","article-title":"Granulocytic sarcoma: 32 cases and review of the literature","volume":"47","author":"Paydas","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/ajcp\/104.4.431","article-title":"Extramedullary tumors of lymphoid or myeloid blasts. The role of immunohistology in diagnosis and classification","volume":"104","author":"Quintanilla-Martinez","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood.V42.5.721.721","article-title":"Chloroma and other myeloblastic tumors","volume":"42","author":"Muss","year":"1973","journal-title":"Blood"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/1097-0142(197909)44:3<1017::AID-CNCR2820440333>3.0.CO;2-I","article-title":"Granulocytic sarcoma preceding acute leukemia: a report of six cases","volume":"44","author":"Krause","year":"1979","journal-title":"Cancer"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/1097-0142(19811015)48:8<1819::AID-CNCR2820480819>3.0.CO;2-6","article-title":"Ovarian granulocytic sarcoma as the primary manifestation of acute infantile myelomonocytic leukemia","volume":"48","author":"Morgan","year":"1981","journal-title":"Cancer"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1046\/j.1365-2141.2003.04231.x","article-title":"Granulocytic sarcoma of main biliary ducts","volume":"121","author":"Ascani","year":"2003","journal-title":"Br J Haematol"},{"key":"R12-20230922","first-page":"790","article-title":"Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections","volume":"119","author":"Roth","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1309\/WWW7-DG6X-HC16-D7J2","article-title":"Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow","volume":"114","author":"Chang","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00000478-199310000-00006","article-title":"Extramedullary myeloid cell tumors. An immunohistochemical and morphologic study of 28 cases","volume":"17","author":"Traweek","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.leukres.2004.01.022","article-title":"Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution","volume":"28","author":"Breccia","year":"2004","journal-title":"Leuk Res"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00432-015-1977-3","article-title":"Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis","volume":"141","author":"Xu","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3892\/ol.2015.3189","article-title":"Prognostic value of the expression of phosphatase and tensin homolog and CD44 in elderly patients with refractory acute myeloid leukemia","volume":"10","author":"Huang","year":"2015","journal-title":"Oncol Lett"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2006-05-024844","article-title":"CXCR4 is a prognostic marker in acute myelogenous leukemia","volume":"109","author":"Spoo","year":"2007","journal-title":"Blood"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1158\/0008-5472.CAN-03-3693","article-title":"CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD\/SCID mice","volume":"64","author":"Tavor","year":"2004","journal-title":"Cancer Res"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0301-472X(01)00741-X","article-title":"The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow","volume":"29","author":"Shen","year":"2001","journal-title":"Exp Hematol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1074\/jbc.R100038200","article-title":"Signaling properties of hyaluronan receptors","volume":"277","author":"Turley","year":"2002","journal-title":"J Biol Chem"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1126\/science.3576199","article-title":"Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing","volume":"236","author":"Cunningham","year":"1987","journal-title":"Science"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1034\/j.1600-0609.2002.02713.x","article-title":"Penile chloroma in a patient with secondary acute myeloid leukemia","volume":"68","author":"Szomor","year":"2002","journal-title":"Eur J Haematol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software\u2019EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.22233","article-title":"Acute myeloid leukemia: epidemiology and etiology","volume":"107","author":"Deschler","year":"2006","journal-title":"Cancer"},{"key":"R27-20230922","first-page":"946","article-title":"De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance","volume":"10","author":"Gahn","year":"1996","journal-title":"Leukemia"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1365-2141.2003.03981.x","article-title":"Cytogenetic heterogeneity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 study","volume":"120","author":"Miyazaki","year":"2003","journal-title":"Br J Haematol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1600-0609.2004.00397.x","article-title":"Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experience","volume":"74","author":"Yanada","year":"2005","journal-title":"Eur J Haematol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s12032-011-0104-9","article-title":"Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia","volume":"29","author":"Djunic","year":"2012","journal-title":"Med Oncol"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0145-2126(03)00180-2","article-title":"Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia","volume":"28","author":"Chang","year":"2004","journal-title":"Leuk Res"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.4081\/rt.2009.e51","article-title":"Diagnostic confusion resulting from CD56 expression by cutaneous myeloid sarcoma","volume":"1","author":"Ho","year":"2009","journal-title":"Rare Tumors"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.urology.2004.05.021","article-title":"Testicular granulocytic sarcoma, a source of diagnostic confusion","volume":"64","author":"Constantinou","year":"2004","journal-title":"Urology"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1084\/jem.163.2.414","article-title":"T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia","volume":"163","author":"Cheng","year":"1986","journal-title":"J Exp Med"},{"key":"R35-20230922","first-page":"1263","article-title":"Rearrangements of T-cell receptor delta, gamma and beta genes in acute myeloid leukemia coexpressing T-lymphoid features","volume":"6","author":"Schmidt","year":"1992","journal-title":"Leukemia"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/10428190009065844","article-title":"Idiopathic myelofibrosis developing isolated granulocytic sarcoma with der (1;7)(q10; p10) after splenectomy and finally transforming to acute myelogenous leukemia","volume":"39","author":"Kasahara","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/sj.leu.2402633","article-title":"Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution\u2019s experience","volume":"16","author":"Rubnitz","year":"2002","journal-title":"Leukemia"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1365-2141.2003.04490.x","article-title":"Isolated epidural chloroma with translocation t(15; 17) successfully treated with chemotherapy and all-trans-retinoic acid","volume":"122","author":"Fiegl","year":"2003","journal-title":"Br J Haematol"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2004.06.005","article-title":"Granulocytic sarcoma associated with a der(7;12)(q10;q10)","volume":"156","author":"Cornfield","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.leu.2403645","article-title":"Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia","volume":"19","author":"Nicci","year":"2005","journal-title":"Leukemia"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/104281904000010783","article-title":"Rearrangement of MLL in a patient with congenital acute monoblastic leukemia and granulocytic sarcoma associated with a t(1;11)(p36;q23) translocation","volume":"46","author":"Douet-Guilbert","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0002-9440(10)63052-0","article-title":"Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement","volume":"159","author":"Park","year":"2001","journal-title":"Am J Pathol"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000253592","article-title":"Prognostic factors of treatment outcomes in patients with granulocytic sarcoma","volume":"122","author":"Lan","year":"2009","journal-title":"Acta Haematol"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1182\/blood-2005-01-0178","article-title":"Drug therapy for acute myeloid leukemia","volume":"106","author":"Tallman","year":"2005","journal-title":"Blood"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.184.3.1101","article-title":"A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)","volume":"184","author":"Bleul","year":"1996","journal-title":"J Exp Med"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.185.1.111","article-title":"The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood","volume":"185","author":"Aiuti","year":"1997","journal-title":"J Exp Med"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1158\/0008-5472.CAN-05-0847","article-title":"Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies","volume":"65","author":"Woerner","year":"2005","journal-title":"Cancer Res"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.192.3.313","article-title":"Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes","volume":"192","author":"Tilton","year":"2000","journal-title":"J Exp Med"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","article-title":"Cellular survival: a play in three Akts","volume":"13","author":"Datta","year":"1999","journal-title":"Genes Dev"},{"key":"R50-20230922","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.286.5443.1309","article-title":"Perspectives: signal transduction. Cell survival demands some Rsk","volume":"286","author":"Nebreda","year":"1999","journal-title":"Science"},{"key":"R51-20230922","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2141.2001.03164.x","article-title":"High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia","volume":"115","author":"Crazzolara","year":"2001","journal-title":"Br J Haematol"},{"key":"R52-20230922","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2141.2000.02157.x","article-title":"Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia","volume":"110","author":"Mohle","year":"2000","journal-title":"Br J Haematol"},{"key":"R53-20230922","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2004-04-1440","article-title":"Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)\/CXCR4 axis","volume":"105","author":"Fukuda","year":"2005","journal-title":"Blood"},{"key":"R54-20230922","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa074306","article-title":"Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia","volume":"358","author":"Schlenk","year":"2008","journal-title":"N Engl J Med"},{"key":"R55-20230922","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.molcel.2009.09.019","article-title":"Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes","volume":"36","author":"Choudhary","year":"2009","journal-title":"Mol Cell"},{"key":"R56-20230922","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MOH.0b013e3282f3ded0","article-title":"New molecular concepts and targets in acute myeloid leukemia","volume":"15","author":"Buzzai","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"R57-20230922","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.molmed.2007.09.003","article-title":"Right on target: eradicating leukemic stem cells","volume":"13","author":"Krause","year":"2007","journal-title":"Trends Mol Med"},{"key":"R58-20230922","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1182\/blood.V80.11.2729.2729","article-title":"Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype","volume":"80","author":"Drach","year":"1992","journal-title":"Blood"},{"key":"R59-20230922","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI7615","article-title":"The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow","volume":"104","author":"Peled","year":"1999","journal-title":"J Clin Invest"},{"key":"R60-20230922","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1084\/jem.187.5.753","article-title":"B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement","volume":"187","author":"Bleul","year":"1998","journal-title":"J Exp Med"},{"key":"R61-20230922","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/annonc\/mdh268","article-title":"CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature","volume":"15","author":"Bekkenk","year":"2004","journal-title":"Ann Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201611000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:15:53Z","timestamp":1695406553000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201611000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000727","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}